Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy

Kim, Hyeong Seok; Kim, Hongbeom; Kwon, Wooil; Han, Youngmin; Byun, Yoonhyeong; Kang, Jae Seung; Choi, Yoo Jin; Jang, Jin Young

doi:10.1007/s00464-020-07551-2

Cited by 16 publications

(34 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As previously described, the CR‐POPF rate is a representative indicator of surgical outcomes in pancreatic surgery 6 . Similar CR‐POPF (10.2% vs 14.4%, P = .09) and mortality (2.1% vs 3.7%, P = .47) rates between RAPD and open PD have been observed, 11 consistent with our results.…”

Section: Discussionsupporting

confidence: 91%

“…No intergroup difference was observed between the two groups while controlling the PJ method. RAPD also enables a shorter postoperative hospital stay, which is consistent with previous studies 4,6,7 . Smaller incisions allow better cosmetic results with lesser postoperative pain scores and earlier recovery in the RAPD group 4,6 .…”

Section: Discussionsupporting

confidence: 86%

“…We initially performed RAPD for patients with benign or borderline malignancy; however, we have expanded its indications for patients with malignancy, eventually accounting for 70%‐80% of the total RAPD. We have demonstrated the safety and feasibility of RAPD through previous studies 4,6,7 ; increasing the RAPD rate thereafter. During the first 2 years, RAPD took approximately 7 hours, but it eventually decreased to approximately 5 hours.…”

Section: Discussionmentioning

confidence: 80%

“…In RAPD, combined‐use laparoscopy during resection is utilized in many centers, including our institute, as it enables tactile feedback, rapidly adjustable and wider camera view, prompt instrument change, and better and immediate control of the assistant’s movements 4,6 …”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

ROBOT‐assisted pancreatoduodenectomy in 300 consecutive cases: Annual trend analysis and propensity score‐matched comparison of perioperative and long‐term oncologic outcomes with the open method

Kim

Han

et al. 2021

J Hepato Biliary Pancreat

Self Cite

View full text Add to dashboard Cite

Background/Purpose We previously reported perioperative and oncologic outcomes of robot‐assisted pancreatoduodenectomy (RAPD); however, the follow‐up period in RAPD was relatively short, and disease‐matched survival analyses were lacking. Therefore, this study investigated time trends of perioperative and long‐term disease‐matched outcomes of RAPD. Methods Annual clinicopathologic outcomes of 328 patients with RAPD between 2015 and 2020 were analyzed and compared with 929 patients with open PD using the propensity score‐matched (PSM) analysis based on postoperative pancreatic fistula (POPF) risk and oncologic variables in malignant patients. Results Robot‐assisted pancreatoduodenectomy cases increased from 10 (6.3%) in 2015 to 116 (50.2% of total PD) in 2020, with malignancy proportion increasing from 50.0% to 80.2%. POPF risk‐based PSM analysis showed that compared with open PD, RAPD had younger patients (63.7 vs 65.6 years, P = .018), longer operation time (339.1 vs 290.0 min, P < .001); however, estimated blood loss (P = .275), complications (17.1% vs 18.3%, P = .702), and clinically relevant POPF (9.8% vs 11.1%, P = .584) were similar with shorter postoperative hospital stay (10.8 vs 15.6 days, P < .001). In disease and stage‐matched malignant patients, R0 resection (93.9% vs 91.2%, P = .376), total retrieved lymph node (18.2 vs 19.9, P = .058), and 5‐year survival rate (57.3% vs 60.6%, P = .406) were similar between RAPD and open PD, also in pancreatic cancer patients (31.6% vs 26.3%, P = .068). Conclusions Robot‐assisted pancreatoduodenectomy demonstrated similar perioperative outcomes with earlier recovery and equivalent long‐term survival with open PD. RAPD is safe and feasible for periampullary lesions, including pancreatic cancers, and its role will expand in the era of minimally invasive surgery.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionsupporting

confidence: 86%

Section: Discussionmentioning

confidence: 80%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

ROBOT‐assisted pancreatoduodenectomy in 300 consecutive cases: Annual trend analysis and propensity score‐matched comparison of perioperative and long‐term oncologic outcomes with the open method

Kim

Han

et al. 2021

J Hepato Biliary Pancreat

Self Cite

View full text Add to dashboard Cite

show abstract

“…Hybrid PD combines the use of robots and laparoscopy wherein resection is performed laparoscopically and reconstruction is performed robotically. [29][30][31] Kim et al 31 compared 153 cases of hybrid PD and 710 cases of OPD using propensity score matching (PSM) analysis. Similar to the comparison between RPD and OPD, the operative duration was longer in hybrid PD than in OPD (361.2 ± 88.1 vs 307.7 ± 86.0 min, P < .001).…”

Section: Hybrid Pancreatoduodenectomymentioning

confidence: 99%

The current status and future directions of robotic pancreatectomy

Nakata

Nakamura

2021

Annals of Gastroent Surgery

View full text Add to dashboard Cite

Robotic distal pancreatectomy (RDP) and robotic pancreatoduodenectomy (RPD) were first described in 2002 and 2003, respectively. 1,2 Several systematic reviews and cohort studies have subsequently shown that robotic pancreatectomy has better or comparable perioperative outcomes compared with conventional open or laparoscopic pancreatectomy. Therefore, in the future, robot pancreatectomy could become an alternative to conventional surgery; however, its use is still controversial. To promote a better understanding of robotic pancreatectomy, we reviewed its current status and future perspectives. | CURRENT TRENDS IN ROBOTI C PAN CRE ATEC TOMYConsidering the number of studies on robotic pancreatectomy, its use is gradually expanding. However, there have been few reports of its trend of use based on national databases. Recently, Hoehn et al 3

show abstract

Robotic Resection for Pancreatic Cancer

Qin

2023

The Pancreas

View full text Add to dashboard Cite

Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy

Cited by 16 publications

References 26 publications

ROBOT‐assisted pancreatoduodenectomy in 300 consecutive cases: Annual trend analysis and propensity score‐matched comparison of perioperative and long‐term oncologic outcomes with the open method

ROBOT‐assisted pancreatoduodenectomy in 300 consecutive cases: Annual trend analysis and propensity score‐matched comparison of perioperative and long‐term oncologic outcomes with the open method

The current status and future directions of robotic pancreatectomy

Robotic Resection for Pancreatic Cancer

Contact Info

Product

Resources

About